Top Vascular Grafts Companies

Vascular Grafts Market size was valued at USD 1.6 Billion in 2023 and is poised to grow from USD 1.72 Billion in 2024 to USD 3 Billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Vascular graft manufacturers should focus on making their products more affordable to enhance the accessibility to vascular procedures. Addressing the risks of complications and failures will also be crucial in determining the vascular grafts industry growth potential going forward. Vascular grafts providers should also focus on gaining new approvals for advanced vascular grafts designed for minimally invasive procedures.  'Medtronic ', 'Terumo ', 'C. R. Bard ', 'B. Braun Melsungen AG ', 'Cardinal Health ', 'Endologix ', 'LeMaitre Vascular ', 'Cook Medical ', 'Maquet ', 'Gore Medical'

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from cardiovascular diseases such as atherosclerosis, coronary artery disease, and peripheral artery disease.  These indications are being treated with vascular repair procedures and surgeries thereby driving vascular grafts sales as well.  

Development of Bioengineered Vascular Grafts: Bioengineered vascular grafts mimic the function of blood vessels and reduce the risk of infection and rejection that is prevalent in conventional vascular grafts.  The use of bioresorbable materials and regenerative medicine approaches in vascular graft development is expected to offer a plethora of new opportunities for new as well as established vascular graft companies in the long run.  

North America secures the top spot when it comes to global vascular grafts demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and rising prevalence of diseases requiring vascular treatment and surgeries are helping the high vascular grafts market share of this region. The United States is slated to emerge as the most opportune market in North America owing to surge in geriatric patient population. Canada is also estimated to boost the demand for vascular grafts in this region going forward. Availability of favorable reimbursement policies and quick adoption of advanced medical technologies are also expected to bolster market growth in North America through 2031.